Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 200, Issue -, Pages S39-S48Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/605035
Keywords
-
Categories
Funding
- National Institutes of Health National Center for Research Resources [1KL2RR025009]
Ask authors/readers for more resources
Rotavirus vaccines hold promise to decrease the burden of severe diarrhea in the poorest countries, where 85% of deaths due to rotavirus occur. However, the potency of live oral vaccines is lower in these challenging settings than in middle- and upper-income countries. Many hypotheses have been suggested to explain these differences that could provide clues to improve the ultimate success of these novel vaccines. Although introduction today of even moderately effective vaccines will decrease the morbidity and mortality associated with rotavirus in low-income settings, research is urgently needed to understand why these differences in efficacy occur and what could be done to improve vaccine performance to maximize the life-saving benefits of vaccination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available